The Cellexus Life Science Blog
Keep up to date with Cellexus, our products and the life sciences industry with the Cellexus Life Science blog.
Phage Futures Europe: 25 – 26 September
Meet our CEO, Gavin Hands, and Sales and Marketing Director, Craig T Loftus, and see the CellMaker in action at…
Bacteriophage amplification results using the CellMaker
One of the main applications of the CellMaker bioreactor system is bacteriophage amplification. We have been working with numerous companies…
Culturing E. coli using high optical density media in the CellMaker
Researchers from the University of Dundee used the CellMaker on an Escherichia coli (E. coli) fermentation run. High cell density…
Welcome to our new website!
Over the last few weeks, we’ve been writing, designing, editing, photographing and then re-writing and re-editing to create a brand…
Protease expression in a CellMaker single-use bioreactor using high optical density media
Researchers from the University of Dundee conducted an Escherichia coli (E. coli) fermentation run using the CellMaker system. A His-tagged…
Using the CellMaker to produce and increase expression levels of a protein in Pichia pastoris
The Laboratory of Molecular Biology in Cambridge used the CellMaker Regular to increase protein expression yields of a 44kDa His-tagged…
Testing the suitability of the CellMaker system for the growth of brewers’ yeast
Working with the International Centre for Brewing and Distilling (ICBD), Heriot Watt University, Edinburgh and supported by the Scottish Funding…
Growing algae cells with the CellMaker
Dunaliella is a unicellular, biflagellate, photoautotrophic green microalga found in extreme, salt-water conditions around the globe. Dunaliella is currently exploited…
Proteon Pharmaceuticals
Proteon Pharmaceuticals produce pioneering and innovative treatments, medicines and vaccines in the veterinary industry. When they turned their attention to…
What is a single-use airlift bioreactor?
The CellMaker range of bioreactors use a patented airlift technology unique to Cellexus. We have dedicated more than a decade…